Uterine adenosarcomas: A dual-institution experience
Access
info:eu-repo/semantics/closedAccessDate
2017Author
Özgü, EmreNarin, Mehmet Ali
Yalçın, Hakan Raşit
Taşçı, Tolga
Güngör, Tayfun
Çavuşoğlu, Deniz
Meydanlı, Mehmet Mutlu
Tulunay, Gökhan
Metadata
Show full item recordCitation
Özgü, E., Narin, M. A., Yalçın, H. R., Taşçı, T., Güngör, T., Çavuşoğlu, D., ... & Tulunay, G. (2017). Uterine adenosarcomas: A dual-institution experience. Journal of Obstetrics and Gynaecology, 37(1), 93-96.Abstract
There has been limited literature about treatment and follow-up strategies of uterine adenosarcomas because of their rare nature. For this study we retrospectively investigated the medical database of the two major womens’ health hospitals in Turkey. A total of 15 patients were identified from the hospital’s database. Median follow-up was 86.43 months for all patients. Seven out of 15 patients had recurrences during their follow-up. Among these 7 patients, 4 of them had stage IA disease. Median Disease Free Survival (DFS) and Overall Survival (OS) were calculated as 41.47 and 57.21 months, respectively. According to our study, polypoid tumours confined to the uterus with superficial myometrial invasion can be treated without comprehensive surgical staging. We believe that, publishing all the data in an organised manner even though they are small in size, gives us an opportunity to design meta-analysis for the development of more appropriate treatment strategies. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Source
Journal of Obstetrics and GynaecologyVolume
37Issue
1Collections
- Makale Koleksiyonu [524]
- Scopus İndeksli Yayınlar Koleksiyonu [2695]
- WoS İndeksli Yayınlar Koleksiyonu [2986]